ReviewThe oncologist2020

Metastatic Thymoma Harboring a Deleterious BRCA2 Mutation Derives Durable Clinical Benefit from Olaparib.

Daniel R Principe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.